Description: 
This is an online buprenorphine training course supported by the American Society of Addiction Medicine. Includes supplemental case studies.
Source: 
Clinical Tools, Inc.
field_vote: 
Description: 
Link to upcoming buprenorphine training events, both DATA and non-DATA qualifying.
Source: 
Substance Abuse and Mental Health Services Administration (SAMHSA)
field_vote: 
Description: 
A systematic review and economic evaluation of methadone and buprenorphine for the management of opioid dependence.
Source: 
Health Technology Assessment; Vol 11: number 9. Connock et al., 2007.
field_vote: 
Description: 
This study examined the responses of older adults to the Drug Abuse Problem Assessment for Primary Care (DAPA-PC), a computerized drug and alcohol abuse screening instrument developed for primary care settings.
Source: 
American Journal of Drug and Alcohol Abuse
field_vote: 
Description: 
This page links to the full text, summary, and physician waiver requirements under DATA 2000.
Source: 
Substance Abuse and Mental Health Services Administration (SAMHSA)
field_vote: 
Description: 
This form is for physicians to notify the DEA (through the Substance Abuse and Mental Health Services Administration) of their intent to use Schedule III, IV, or V drugs for treatment of opioid dependent patients.
Source: 
The National Alliance of Advocates for Buprenorphine Treatment (NAABT)
field_vote: 
Description: 
This PDF Document contains the Clinical Opioid Withdrawal Scale (COWS), a common instrument used to assess a patient's opioid withdrawal severity.
Source: 
California Society of Addiction Medicine (CSAM)
field_vote: 
Description: 
This publication discusses the medical co-management of hepatitis infection and opioid abuse.
Source: 
Center for Substance Abuse Treatment (CSAT)
field_vote: 
Description: 
SAMHSA's list of upcoming live and online buprenorphine training programs.
Source: 
Substance Abuse and Mental Health Services Administration (SAMHSA)
field_vote: 

Pages

Subscribe to Becoming waivered